查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1672068

全球精准医疗市场研究报告 - 产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

Global Precision Medicine Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 130 Pages | 商品交期: 最快1-2个工作天内

价格

全球精准医疗市场规模预计将从 2024 年的 794.5 亿美元成长到 2033 年的 3,296.9 亿美元，在 2026 年至 2033 年的预测期内，年复合成长率(CAGR) 将达到 17.13%。

精准医疗市场正在快速成长，这得益于基因组学、生物技术和资料分析方面的进步，可以为个别患者提供个人化的治疗方案。随着医疗保健转向个人化护理，对精准医疗解决方案的需求正在增加，特别是在肿瘤学领域，标靶疗法正在彻底改变癌症治疗。基因检测和生物标记识别的整合使医疗保健提供者能够制定客製化的治疗计划，以优化治疗效果并最大限度地减少副作用。由于患者和服务提供者都在寻求更有效、更个人化的医疗保健解决方案，预计这一趋势将推动市场向前发展。

科技和资料管理的创新也在塑造精准医疗市场的未来。人工智慧和机器学习的兴起增强了分析复杂资料集的能力，从而改善了患者分层和治疗结果。此外，生物资讯学的进步促进了基因组资料与临床实践的整合，使医疗保健提供者能够根据患者独特的基因特征做出明智的决定。随着这些技术的不断发展，市场可能见证精准医疗应用在各个治疗领域的多样化，包括罕见疾病和慢性病。

此外，随着製药公司和医疗保健组织认识到个人化治疗的潜力，精准医疗市场将受益于研发投资的增加。学术机构、产业利害关係人和监管机构之间的合作努力对于推动临床试验和确保精准医疗策略的成功实施至关重要。随着情势的发展，重点将转向将精准医疗整合到标准护理途径中，强调多学科方法在提供最佳患者治疗结果方面的重要性。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

报告涵盖的细分

依技术分类

  • 生物资讯学
  • 大数据分析
  • 药物研发
  • 基因定序
  • 伴随诊断
  • 其他的

按应用

  • 中枢神经系统
  • 免疫学
  • 肿瘤学
  • 呼吸系统
  • 其他的

按最终用途

  • 诊断公司
  • 製药公司
  • 医疗保健 IT 公司
  • 其他的

透过定序技术

  • 合成定序
  • 离子半导体定序
  • 连接定序
  • 焦磷酸定序
  • 单分子即时定序
  • 链终止定序
  • 奈米孔定序

按产品

  • 耗材
  • 仪器
  • 服务

依给药途径

  • 口服
  • 注射剂

透过药物

  • 艾乐替尼
  • 奥希替尼
  • 美泊利单抗
  • 月桂酰阿立哌唑
  • 其他的
  • 公司简介
  • Biocrates 生命科学
  • Tepnel 製药服务
  • 诺华
  • Qigen
  • Quest 诊断公司
  • 美纳里尼硅生物系统公司
  • 奈米串科技
  • 鹰基因公司
  • 辉瑞
  • 原子学
  • 罗氏
  • 梯瓦製药
  • 以上清单可以自订。

目录

第 1 章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第三章：精准医疗产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 依技术进行市场吸引力分析
    • 市场吸引力分析：按应用
    • 按最终用途进行的市场吸引力分析
    • 透过定序技术进行市场吸引力分析
    • 按产品进行市场吸引力分析
    • 按给药途径进行的市场吸引力分析
    • 药品市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球精准医疗市场分析：按技术

  • 技术概览
  • 按技术进行的历史和预测数据分析
  • 生物资讯学
  • 大数据分析
  • 药物研发
  • 基因定序
  • 伴随诊断
  • 其他的

第 6 章：全球精准医疗市场分析：按应用

  • 概述：按应用
  • 历史和预测数据分析：按应用
  • 中枢神经系统
  • 免疫学
  • 肿瘤学
  • 呼吸系统
  • 其他的

第 7 章：全球精准医疗市场分析：依最终用途

  • 按最终用途概述
  • 按最终用途进行的历史和预测数据分析
  • 诊断公司
  • 製药公司
  • 医疗保健 IT 公司
  • 其他的

第 8 章：全球精准医疗市场分析：依定序技术

  • 定序技术概览
  • 透过定序技术进行历史和预测数据分析
  • 合成定序
  • 离子半导体定序
  • 连接定序
  • 焦磷酸定序
  • 单分子即时定序
  • 链终止定序
  • 奈米孔定序

第 9 章：全球精准医疗市场分析：按产品

  • 产品概览
  • 按产品进行的历史和预测数据分析
  • 耗材
  • 仪器
  • 服务

第 10 章：全球精准医疗市场分析：依给药途径

  • 依给药途径概述
  • 按给药途径进行的历史和预测数据分析
  • 口服
  • 注射剂

第 11 章：全球精准医疗市场分析：按药物

  • 药物概览
  • 按药物进行的历史和预测数据分析
  • 艾乐替尼
  • 奥希替尼
  • 美泊利单抗
  • 月桂酰阿立哌唑
  • 其他的

第 12 章：全球精准医疗市场分析：按地区划分

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测数据销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第 13 章：精准医疗公司的竞争格局

  • 精准医疗市场竞争格局
  • 伙伴关係/合作/协议
  • 合併与收购
  • 新产品发布
  • 其他进展

第 14 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Biocrates Life Sciences
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Tepnel Pharma Services
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Novartis
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Qiagen
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Quest Diagnostics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Menarini Silicon Biosystems
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • NanoString Technologies
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Eagle Genomics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Pfizer
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Intomics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Roche
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Teva Pharmaceutical
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Product Code: VMR11214898

Global Precision Medicine Market size is anticipated to grow from USD 79.45 Billion in 2024 to USD 329.69 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 17.13% during the forecast period of 2026 to 2033.

The precision medicine market is experiencing rapid growth, driven by advancements in genomics, biotechnology, and data analytics that enable tailored treatment approaches for individual patients. As healthcare shifts towards personalized care, the demand for precision medicine solutions is increasing, particularly in oncology, where targeted therapies are revolutionizing cancer treatment. The integration of genetic testing and biomarker identification is allowing healthcare providers to develop customized treatment plans that optimize therapeutic efficacy and minimize adverse effects. This trend is expected to propel the market forward, as patients and providers alike seek more effective and individualized healthcare solutions.

Innovations in technology and data management are also shaping the future of the precision medicine market. The rise of artificial intelligence and machine learning is enhancing the ability to analyze complex datasets, leading to improved patient stratification and treatment outcomes. Additionally, advancements in bioinformatics are facilitating the integration of genomic data into clinical practice, enabling healthcare providers to make informed decisions based on a patient's unique genetic profile. As these technologies continue to evolve, the market is likely to witness a diversification of precision medicine applications across various therapeutic areas, including rare diseases and chronic conditions.

Moreover, the precision medicine market will benefit from increased investment in research and development, as pharmaceutical companies and healthcare organizations recognize the potential of personalized therapies. Collaborative efforts between academic institutions, industry stakeholders, and regulatory bodies will be crucial in advancing clinical trials and ensuring the successful implementation of precision medicine strategies. As the landscape evolves, the focus will shift towards integrating precision medicine into standard care pathways, emphasizing the importance of multidisciplinary approaches in delivering optimal patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Technology

  • Bioinformatics
  • Big Data Analytics
  • Drug Discovery
  • Gene Sequencing
  • Companion Diagnostics
  • Others

By Application

  • CNS
  • Immunology
  • Oncology
  • Respiratory
  • Others

By End-Use

  • Diagnostic Companies
  • Pharmaceutical Companies
  • Healthcare IT companies
  • Others

By Sequencing Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Single Molecule Real Time Sequencing
  • Chain Termination Sequencing
  • Nanopore Sequencing

By Product

  • Consumables
  • Instruments
  • Services

By Route of Administration

  • Oral
  • Injectable

By Drugs

  • Alectinib
  • Osimertinib
  • Mepolizumab
  • Aripiprazole Lauroxil
  • Others
  • COMPANIES PROFILED
  • Biocrates Life Sciences
  • Tepnel Pharma Services
  • Novartis
  • Qiagen
  • Quest Diagnostics
  • Menarini Silicon Biosystems
  • NanoString Technologies
  • Eagle Genomics
  • Pfizer
  • Intomics
  • Roche
  • Teva Pharmaceutical
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PRECISION MEDICINE INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-Use
    • 3.7.4 Market Attractiveness Analysis By Sequencing Technology
    • 3.7.5 Market Attractiveness Analysis By Product
    • 3.7.6 Market Attractiveness Analysis By Route of Administration
    • 3.7.7 Market Attractiveness Analysis By Drugs
    • 3.7.8 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY TECHNOLOGY

  • 5.1. Overview By Technology
  • 5.2. Historical and Forecast Data Analysis By Technology
  • 5.3. Bioinformatics Historic and Forecast Sales By Regions
  • 5.4. Big Data Analytics Historic and Forecast Sales By Regions
  • 5.5. Drug Discovery Historic and Forecast Sales By Regions
  • 5.6. Gene Sequencing Historic and Forecast Sales By Regions
  • 5.7. Companion Diagnostics Historic and Forecast Sales By Regions
  • 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. CNS Historic and Forecast Sales By Regions
  • 6.4. Immunology Historic and Forecast Sales By Regions
  • 6.5. Oncology Historic and Forecast Sales By Regions
  • 6.6. Respiratory Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-Use
  • 7.2. Historical and Forecast Data Analysis By End-Use
  • 7.3. Diagnostic Companies Historic and Forecast Sales By Regions
  • 7.4. Pharmaceutical Companies Historic and Forecast Sales By Regions
  • 7.5. Healthcare IT companies Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY SEQUENCING TECHNOLOGY

  • 8.1. Overview By Sequencing Technology
  • 8.2. Historical and Forecast Data Analysis By Sequencing Technology
  • 8.3. Sequencing by Synthesis Historic and Forecast Sales By Regions
  • 8.4. Ion Semiconductor Sequencing Historic and Forecast Sales By Regions
  • 8.5. Sequencing by Ligation Historic and Forecast Sales By Regions
  • 8.6. Pyrosequencing Historic and Forecast Sales By Regions
  • 8.7. Single Molecule Real Time Sequencing Historic and Forecast Sales By Regions
  • 8.8. Chain Termination Sequencing Historic and Forecast Sales By Regions
  • 8.9. Nanopore Sequencing Historic and Forecast Sales By Regions

9. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY PRODUCT

  • 9.1. Overview By Product
  • 9.2. Historical and Forecast Data Analysis By Product
  • 9.3. Consumables Historic and Forecast Sales By Regions
  • 9.4. Instruments Historic and Forecast Sales By Regions
  • 9.5. Services Historic and Forecast Sales By Regions

10. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 10.1. Overview By Route of Administration
  • 10.2. Historical and Forecast Data Analysis By Route of Administration
  • 10.3. Oral Historic and Forecast Sales By Regions
  • 10.4. Injectable Historic and Forecast Sales By Regions

11. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY DRUGS

  • 11.1. Overview By Drugs
  • 11.2. Historical and Forecast Data Analysis By Drugs
  • 11.3. Alectinib Historic and Forecast Sales By Regions
  • 11.4. Osimertinib Historic and Forecast Sales By Regions
  • 11.5. Mepolizumab Historic and Forecast Sales By Regions
  • 11.6. Aripiprazole Lauroxil Historic and Forecast Sales By Regions
  • 11.7. Others Historic and Forecast Sales By Regions

12. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY GEOGRAPHY

  • 12.1. Regional Outlook
  • 12.2. Introduction
  • 12.3. North America Sales Analysis
    • 12.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.3.2 North America By Segment Sales Analysis
    • 12.3.3 North America By Country Sales Analysis
    • 12.3.4 United States Sales Analysis
    • 12.3.5 Canada Sales Analysis
    • 12.3.6 Mexico Sales Analysis
  • 12.4. Europe Sales Analysis
    • 12.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.4.2 Europe By Segment Sales Analysis
    • 12.4.3 Europe By Country Sales Analysis
    • 12.4.4 United Kingdom Sales Analysis
    • 12.4.5 France Sales Analysis
    • 12.4.6 Germany Sales Analysis
    • 12.4.7 Italy Sales Analysis
    • 12.4.8 Russia Sales Analysis
    • 12.4.9 Rest Of Europe Sales Analysis
  • 12.5. Asia Pacific Sales Analysis
    • 12.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.5.2 Asia Pacific By Segment Sales Analysis
    • 12.5.3 Asia Pacific By Country Sales Analysis
    • 12.5.4 China Sales Analysis
    • 12.5.5 India Sales Analysis
    • 12.5.6 Japan Sales Analysis
    • 12.5.7 South Korea Sales Analysis
    • 12.5.8 Australia Sales Analysis
    • 12.5.9 South East Asia Sales Analysis
    • 12.5.10 Rest Of Asia Pacific Sales Analysis
  • 12.6. Latin America Sales Analysis
    • 12.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.6.2 Latin America By Segment Sales Analysis
    • 12.6.3 Latin America By Country Sales Analysis
    • 12.6.4 Brazil Sales Analysis
    • 12.6.5 Argentina Sales Analysis
    • 12.6.6 Peru Sales Analysis
    • 12.6.7 Chile Sales Analysis
    • 12.6.8 Rest of Latin America Sales Analysis
  • 12.7. Middle East & Africa Sales Analysis
    • 12.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.7.2 Middle East & Africa By Segment Sales Analysis
    • 12.7.3 Middle East & Africa By Country Sales Analysis
    • 12.7.4 Saudi Arabia Sales Analysis
    • 12.7.5 UAE Sales Analysis
    • 12.7.6 Israel Sales Analysis
    • 12.7.7 South Africa Sales Analysis
    • 12.7.8 Rest Of Middle East And Africa Sales Analysis

13. COMPETITIVE LANDSCAPE OF THE PRECISION MEDICINE COMPANIES

  • 13.1. Precision Medicine Market Competition
  • 13.2. Partnership/Collaboration/Agreement
  • 13.3. Merger And Acquisitions
  • 13.4. New Product Launch
  • 13.5. Other Developments

14. COMPANY PROFILES OF PRECISION MEDICINE INDUSTRY

  • 14.1. Top Companies Market Share Analysis
  • 14.2. Market Concentration Rate
  • 14.3. Biocrates Life Sciences
    • 14.3.1 Company Overview
    • 14.3.2 Company Revenue
    • 14.3.3 Products
    • 14.3.4 Recent Developments
  • 14.4. Tepnel Pharma Services
    • 14.4.1 Company Overview
    • 14.4.2 Company Revenue
    • 14.4.3 Products
    • 14.4.4 Recent Developments
  • 14.5. Novartis
    • 14.5.1 Company Overview
    • 14.5.2 Company Revenue
    • 14.5.3 Products
    • 14.5.4 Recent Developments
  • 14.6. Qiagen
    • 14.6.1 Company Overview
    • 14.6.2 Company Revenue
    • 14.6.3 Products
    • 14.6.4 Recent Developments
  • 14.7. Quest Diagnostics
    • 14.7.1 Company Overview
    • 14.7.2 Company Revenue
    • 14.7.3 Products
    • 14.7.4 Recent Developments
  • 14.8. Menarini Silicon Biosystems
    • 14.8.1 Company Overview
    • 14.8.2 Company Revenue
    • 14.8.3 Products
    • 14.8.4 Recent Developments
  • 14.9. NanoString Technologies
    • 14.9.1 Company Overview
    • 14.9.2 Company Revenue
    • 14.9.3 Products
    • 14.9.4 Recent Developments
  • 14.10. Eagle Genomics
    • 14.10.1 Company Overview
    • 14.10.2 Company Revenue
    • 14.10.3 Products
    • 14.10.4 Recent Developments
  • 14.11. Pfizer
    • 14.11.1 Company Overview
    • 14.11.2 Company Revenue
    • 14.11.3 Products
    • 14.11.4 Recent Developments
  • 14.12. Intomics
    • 14.12.1 Company Overview
    • 14.12.2 Company Revenue
    • 14.12.3 Products
    • 14.12.4 Recent Developments
  • 14.13. Roche
    • 14.13.1 Company Overview
    • 14.13.2 Company Revenue
    • 14.13.3 Products
    • 14.13.4 Recent Developments
  • 14.14. Teva Pharmaceutical
    • 14.14.1 Company Overview
    • 14.14.2 Company Revenue
    • 14.14.3 Products
    • 14.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Technology (USD MN)
  • Bioinformatics Market Sales By Geography (USD MN)
  • Big Data Analytics Market Sales By Geography (USD MN)
  • Drug Discovery Market Sales By Geography (USD MN)
  • Gene Sequencing Market Sales By Geography (USD MN)
  • Companion Diagnostics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • CNS Market Sales By Geography (USD MN)
  • Immunology Market Sales By Geography (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Respiratory Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Diagnostic Companies Market Sales By Geography (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Healthcare IT companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Sequencing Technology (USD MN)
  • Sequencing by Synthesis Market Sales By Geography (USD MN)
  • Ion Semiconductor Sequencing Market Sales By Geography (USD MN)
  • Sequencing by Ligation Market Sales By Geography (USD MN)
  • Pyrosequencing Market Sales By Geography (USD MN)
  • Single Molecule Real Time Sequencing Market Sales By Geography (USD MN)
  • Chain Termination Sequencing Market Sales By Geography (USD MN)
  • Nanopore Sequencing Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectable Market Sales By Geography (USD MN)
  • Analysis By Drugs (USD MN)
  • Alectinib Market Sales By Geography (USD MN)
  • Osimertinib Market Sales By Geography (USD MN)
  • Mepolizumab Market Sales By Geography (USD MN)
  • Aripiprazole Lauroxil Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Precision Medicine Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Precision Medicine Report
  • Market Research Process
  • Market Research Methodology
  • Global Precision Medicine Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Sequencing Technology
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Drugs
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Technology (USD MN)
  • Bioinformatics Market Sales By Geography (USD MN)
  • Big Data Analytics Market Sales By Geography (USD MN)
  • Drug Discovery Market Sales By Geography (USD MN)
  • Gene Sequencing Market Sales By Geography (USD MN)
  • Companion Diagnostics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • CNS Market Sales By Geography (USD MN)
  • Immunology Market Sales By Geography (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Respiratory Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Diagnostic Companies Market Sales By Geography (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Healthcare IT companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Sequencing Technology (USD MN)
  • Sequencing by Synthesis Market Sales By Geography (USD MN)
  • Ion Semiconductor Sequencing Market Sales By Geography (USD MN)
  • Sequencing by Ligation Market Sales By Geography (USD MN)
  • Pyrosequencing Market Sales By Geography (USD MN)
  • Single Molecule Real Time Sequencing Market Sales By Geography (USD MN)
  • Chain Termination Sequencing Market Sales By Geography (USD MN)
  • Nanopore Sequencing Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectable Market Sales By Geography (USD MN)
  • Global Market Analysis By Drugs (USD MN)
  • Alectinib Market Sales By Geography (USD MN)
  • Osimertinib Market Sales By Geography (USD MN)
  • Mepolizumab Market Sales By Geography (USD MN)
  • Aripiprazole Lauroxil Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.